至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Peptide-based covalent inhibitors of MALT1 paracaspase.

Bioorg. Med. Chem. Lett.. 2019; 
HatcherJohn M,DuGuangyan,FontánLorena,UsIlkay,QiaoQi,ChennamadhavuniSpandan,ShaoJay,WuHao,MelnickAri,GrayNathanael S,ScottDav
Products/Services Used Details Operation
Recombinant Proteins Microsome and plasma stability experiments, and mouse PK studies, were conducted at the Drug Metabolism and Pharmacokinetics laboratory at The Scripps Research Institute, under the supervision of Mike Cameron. Protease profiling was conducted at Genscript USA. Get A Quote

摘要

Potent and selective substrate-based covalent inhibitors of MALT1 protease were developed from the tetrapeptide tool compound Z-VRPR-fmk. To improve cell permeability, we replaced one arginine residue. We further optimized a series of tripeptides and identified compounds that were potent in both a GloSensor reporter assay measuring cellular MALT1 protease activity, and an OCI-Ly3 cell proliferation assay. Example compounds showed good overall selectivity towards cysteine proteases, and one compound was selected for further profiling in ABL-DLBCL cells and xenograft efficacy models.

关键词

Covalent,Inhibitors,Peptide,Prot